Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture (original) (raw)

Abstract

Although much attention has been paid to the removal of hormones from sera and to the development of serum-free media for studies on hormone-responsive cells in culture, little consideration has been given to the possibility that the media components themselves may have hormonal activity. We have found that phenol red, which bears a structural resemblance to some nonsteroidal estrogens and which is used ubiquitously as a pH indicator in tissue culture media, has significant estrogenic activity at the concentrations (15-45 microM) at which it is found in tissue culture media. Phenol red binds to the estrogen receptor of MCF-7 human breast cancer cells with an affinity 0.001% that of estradiol (Kd = 2 X 10(-5) M). It stimulates the proliferation of estrogen receptor-positive MCF-7 breast cancer cells in a dose-dependent manner but has no effect on the growth of estrogen receptor-negative MDA-MB-231 breast cancer cells. At the concentrations present in tissue culture media, phenol red causes partial estrogenic stimulation, increasing cell number to 200% and progesterone receptor content to 300% of that found for cells grown in phenol red-free media, thereby reducing the degree to which exogenous estrogen is able to stimulate responses. The antiestrogens tamoxifen and hydroxytamoxifen inhibit cell proliferation below the control level only when cells are grown in the presence of phenol red; in the absence of phenol red, the antiestrogens do not suppress growth. The estrogenic activity of phenol red should be considered in any studies that utilize estrogen-responsive cells in culture.

2496

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken S. C., Lippman M. E. Effect of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture. Cancer Res. 1985 Apr;45(4):1611–1620. [PubMed] [Google Scholar]
  2. Barnes D., Sato G. Serum-free cell culture: a unifying approach. Cell. 1980 Dec;22(3):649–655. doi: 10.1016/0092-8674(80)90540-1. [DOI] [PubMed] [Google Scholar]
  3. Brown A. M., Jeltsch J. M., Roberts M., Chambon P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6344–6348. doi: 10.1073/pnas.81.20.6344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Butler W. B., Kelsey W. H., Goran N. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens. Cancer Res. 1981 Jan;41(1):82–88. [PubMed] [Google Scholar]
  5. Butler W. B., Kirkland W. L., Gargala T. L., Goran N., Kelsey W. H., Berlinski P. J. Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7). Cancer Res. 1983 Apr;43(4):1637–1641. [PubMed] [Google Scholar]
  6. Coezy E., Borgna J. L., Rochefort H. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res. 1982 Jan;42(1):317–323. [PubMed] [Google Scholar]
  7. Darbre P., Yates J., Curtis S., King R. J. Effect of estradiol on human breast cancer cells in culture. Cancer Res. 1983 Jan;43(1):349–354. [PubMed] [Google Scholar]
  8. Eckert R. L., Katzenellenbogen B. S. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. Cancer Res. 1982 Jan;42(1):139–144. [PubMed] [Google Scholar]
  9. Edery M., Imagawa W., Larson L., Nandi S. Regulation of estrogen and progesterone receptor levels in mouse mammary epithelial cells grown in serum-free collagen gel cultures. Endocrinology. 1985 Jan;116(1):105–112. doi: 10.1210/endo-116-1-105. [DOI] [PubMed] [Google Scholar]
  10. Faye J. C., Jozan S., Redeuilh G., Baulieu E. E., Bayard F. Physicochemical and genetic evidence for specific antiestrogen binding sites. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3158–3162. doi: 10.1073/pnas.80.11.3158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Horwitz K. B., McGuire W. L. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem. 1978 Apr 10;253(7):2223–2228. [PubMed] [Google Scholar]
  12. Katzenellenbogen B. S., Bhakoo H. S., Ferguson E. R., Lan N. C., Tatee T., Tsai T. S., Katzenellenbogen J. A. Estrogen and antiestrogen action in reproductive tissues and tumors. Recent Prog Horm Res. 1979;35:259–300. doi: 10.1016/b978-0-12-571135-7.50010-2. [DOI] [PubMed] [Google Scholar]
  13. Katzenellenbogen B. S., Miller M. A., Mullick A., Sheen Y. Y. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites. Breast Cancer Res Treat. 1985;5(3):231–243. doi: 10.1007/BF01806018. [DOI] [PubMed] [Google Scholar]
  14. Katzenellenbogen B. S., Norman M. J., Eckert R. L., Peltz S. W., Mangel W. F. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res. 1984 Jan;44(1):112–119. [PubMed] [Google Scholar]
  15. King W. J., Greene G. L. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature. 1984 Feb 23;307(5953):745–747. doi: 10.1038/307745a0. [DOI] [PubMed] [Google Scholar]
  16. Kon O. L. An antiestrogen-binding protein in human tissues. J Biol Chem. 1983 Mar 10;258(5):3173–3177. [PubMed] [Google Scholar]
  17. Lippman M., Bolan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 1976 Dec;36(12):4595–4601. [PubMed] [Google Scholar]
  18. Miller M. A., Katzenellenbogen B. S. Characterization and quantitation of antiestrogen binding sites in estrogen receptor-positive and -negative human breast cancer cell lines. Cancer Res. 1983 Jul;43(7):3094–3100. [PubMed] [Google Scholar]
  19. Osborne C. K., Boldt D. H., Estrada P. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. Cancer Res. 1984 Apr;44(4):1433–1439. [PubMed] [Google Scholar]
  20. Osborne C. K., Hobbs K., Clark G. M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 1985 Feb;45(2):584–590. [PubMed] [Google Scholar]
  21. Page M. J., Field J. K., Everett N. P., Green C. D. Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res. 1983 Mar;43(3):1244–1250. [PubMed] [Google Scholar]
  22. Satyaswaroop P. G., Zaino R. J., Mortel R. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res. 1984 Sep;44(9):4006–4010. [PubMed] [Google Scholar]
  23. Soto A. M., Sonnenschein C. Mechanism of estrogen action on cellular proliferation: evidence for indirect and negative control on cloned breast tumor cells. Biochem Biophys Res Commun. 1984 Aug 16;122(3):1097–1103. doi: 10.1016/0006-291x(84)91204-x. [DOI] [PubMed] [Google Scholar]
  24. Sudo K., Monsma F. J., Jr, Katzenellenbogen B. S. Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat. Endocrinology. 1983 Feb;112(2):425–434. doi: 10.1210/endo-112-2-425. [DOI] [PubMed] [Google Scholar]
  25. Sutherland R. L., Murphy L. C., San Foo M., Green M. D., Whybourne A. M., Krozowski Z. S. High-affinity anti-oestrogen binding site distinct from the oestrogen receptor. Nature. 1980 Nov 20;288(5788):273–275. doi: 10.1038/288273a0. [DOI] [PubMed] [Google Scholar]
  26. Vignon F., Terqui M., Westley B., Derocq D., Rochefort H. Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology. 1980 Apr;106(4):1079–1086. doi: 10.1210/endo-106-4-1079. [DOI] [PubMed] [Google Scholar]
  27. Welshons W. V., Lieberman M. E., Gorski J. Nuclear localization of unoccupied oestrogen receptors. Nature. 1984 Feb 23;307(5953):747–749. doi: 10.1038/307747a0. [DOI] [PubMed] [Google Scholar]
  28. Westley B., May F. E., Brown A. M., Krust A., Chambon P., Lippman M. E., Rochefort H. Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines. J Biol Chem. 1984 Aug 25;259(16):10030–10035. [PubMed] [Google Scholar]
  29. Westley B., Rochefort H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell. 1980 Jun;20(2):353–362. doi: 10.1016/0092-8674(80)90621-2. [DOI] [PubMed] [Google Scholar]
  30. Zaino R. J., Satyaswaroop P. G., Mortel R. Hormonal therapy of human endometrial adenocarcinoma in a nude mouse model. Cancer Res. 1985 Feb;45(2):539–541. [PubMed] [Google Scholar]